Pharmacoeconomics of treating uncomplicated urinary tract infections

International Journal of Antimicrobial Agents

Volumn 11, Issue 3-4, 1999, Pages 247-251

  Rosenberg, M ^a,b  

^a Research Organization Health Decisions   (United States)

^b IL   (United States)

Author keywords

Antibiotic use; Cost effectiveness analysis; Pharmacoeconomics; Urinary tract infections

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; COTRIMOXAZOLE; NITROFURANTOIN; OFLOXACIN;

CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; ESCHERICHIA COLI; FEMALE; HUMAN; MEDICAL CARE; PHARMACOECONOMICS; PRIORITY JOURNAL; PYELONEPHRITIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; VAGINA CANDIDIASIS;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; DRUG COSTS; ESCHERICHIA COLI; HUMANS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 0032897194     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00024-2     Document Type: Conference Paper

References (6)

1. Patton JP, Nash DH, Abrutyn E. Urinary tract infections: economic considerations. Med Clin North Am 1991;75:495-513.
2. Johnson JR, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Int Med 1989;111:906-15.
3. Berg AO. Variations among family physicians' management strategies for lower urinary tract infection in women: a report from the Washington Family Physicians Collaborative Research Network. J Am Board Fam Pract 1991;4:327-30.
4. Stamm WE, Hooton TM. Management of urinary tract infections. New Engl J Med 1993;18:1328-34.
5. Rosenberg MJ, Waugh MS. Empiric treatment of urinary tract infections: a cost-benefit and cost-effectiveness analysis. Presented at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, 16 September 1996.
6. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. J Am Med Assoc 1995;273:41-5.